ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

In Brief: Nobel Prize Awarded to Blobel for Research On Protein Signaling; Work Funded By NIH

October 15, 1999

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000